SE440652B - 4-oxo-4h-pyrido(1,2-a)pyrimidin-3-n-(1h-tetrazol-5-yl) karboxamidderivat och farmaceutisk komposition - Google Patents

4-oxo-4h-pyrido(1,2-a)pyrimidin-3-n-(1h-tetrazol-5-yl) karboxamidderivat och farmaceutisk komposition

Info

Publication number
SE440652B
SE440652B SE7902915A SE7902915A SE440652B SE 440652 B SE440652 B SE 440652B SE 7902915 A SE7902915 A SE 7902915A SE 7902915 A SE7902915 A SE 7902915A SE 440652 B SE440652 B SE 440652B
Authority
SE
Sweden
Prior art keywords
oxo
tetrazol
ethyl
solution
mixture
Prior art date
Application number
SE7902915A
Other languages
English (en)
Swedish (sv)
Other versions
SE7902915L (sv
Inventor
P F Juby
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE7902915L publication Critical patent/SE7902915L/xx
Publication of SE440652B publication Critical patent/SE440652B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
SE7902915A 1978-04-03 1979-04-02 4-oxo-4h-pyrido(1,2-a)pyrimidin-3-n-(1h-tetrazol-5-yl) karboxamidderivat och farmaceutisk komposition SE440652B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/892,714 US4192944A (en) 1978-04-03 1978-04-03 Optionally substituted 4-oxo-4H-pyrido[1,2-a]pyrimidine-3-N-(1H-tetrazol-4-yl)carboxamides and their use as antiallergy agents

Publications (2)

Publication Number Publication Date
SE7902915L SE7902915L (sv) 1979-10-04
SE440652B true SE440652B (sv) 1985-08-12

Family

ID=25400392

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7902915A SE440652B (sv) 1978-04-03 1979-04-02 4-oxo-4h-pyrido(1,2-a)pyrimidin-3-n-(1h-tetrazol-5-yl) karboxamidderivat och farmaceutisk komposition

Country Status (15)

Country Link
US (1) US4192944A (fr)
JP (1) JPS54141797A (fr)
BE (1) BE875246A (fr)
CA (1) CA1117112A (fr)
CH (1) CH643256A5 (fr)
DE (1) DE2913295A1 (fr)
DK (1) DK153485C (fr)
FR (1) FR2423490A1 (fr)
GB (1) GB2019836B (fr)
IE (1) IE48278B1 (fr)
IT (1) IT1116537B (fr)
LU (1) LU81107A1 (fr)
NL (1) NL7902444A (fr)
SE (1) SE440652B (fr)
ZA (1) ZA791525B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU173438B (hu) * 1975-11-27 1979-05-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija novykh proizvodnykh 4-okso-1,6,7,8-/tetragidro-4h-pirido/1,2/pirimidina s zaderzhivajuhhejj vozgoranie aktivnot'ju i protivosvertivajuhhem effektom
US4495189A (en) * 1975-11-27 1985-01-22 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. Condensed pyrimidines
CA1157858A (fr) 1979-12-03 1983-11-29 Ikuo Ueda Derives de quinazoline
IE51802B1 (en) * 1979-12-03 1987-04-01 Fujisawa Pharmaceutical Co Quinazoline derivatives,processes for their preparation and pharmaceutical compositions containing them
JPS63183581A (ja) * 1985-10-03 1988-07-28 Tokyo Tanabe Co Ltd ピリド〔１，２−ａ〕ピリミジン誘導体、その製造法及びそれを有効成分とするアレルギ−疾患治療薬
HU201551B (en) * 1988-02-03 1990-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing 4-oxo-4h-pyrido(1,2-a)pyrimidine-3-carboxylic acid amide derivatives and pharmaceutical compositions comprising same
US6295995B1 (en) * 2000-04-07 2001-10-02 Irene D. Ewaka Permanently covered rigid or semi-rigid mounting piece for an article of fashion

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3072485A (en) * 1960-08-24 1963-01-08 Eastman Kodak Co Optically sensitized azido polymers for photomechanical resist compositions
CH538494A (de) * 1966-11-02 1973-06-30 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung neuer Homopyrimidazol-Derivate
US3960847A (en) * 1972-04-17 1976-06-01 E. R. Squibb & Sons, Inc. 9-Substituted-4-oxopyrido(1,2-α)pyrimidine-3-carboxylic acids and derivatives thereof
US3929787A (en) * 1974-04-22 1975-12-30 Squibb & Sons Inc 6,7,8,9-Tetrahydro-pyrido(1,2-a)pyrimidin-4-ones
SU685156A3 (ru) * 1975-08-01 1979-09-05 Пфайзер Инк (Фирма) Способ получени -(5-тетразолил(1-оксо-1н-пиримидо-)1,2-а) хинолин-2-карбоксамида
US4017625A (en) * 1975-08-01 1977-04-12 Pfizer Inc. Anti-allergic N-(5-tetrazolyl)-1-oxo-1H-6-alkoxypyrimido-[1,2-a]quinoline-2-carboxamides and intermediates therefor
HU173438B (hu) * 1975-11-27 1979-05-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija novykh proizvodnykh 4-okso-1,6,7,8-/tetragidro-4h-pirido/1,2/pirimidina s zaderzhivajuhhejj vozgoranie aktivnot'ju i protivosvertivajuhhem effektom
US4122274A (en) * 1977-05-25 1978-10-24 Bristol-Myers Company 3-Tetrazolo-5,6,7,8-substituted-pyrido[1,2-a]pyrimidin-4-ones

Also Published As

Publication number Publication date
DE2913295A1 (de) 1979-10-18
IE790950L (en) 1979-10-03
BE875246A (fr) 1979-10-01
GB2019836B (en) 1982-06-03
CA1117112A (fr) 1982-01-26
DK153485B (da) 1988-07-18
FR2423490B1 (fr) 1982-03-19
CH643256A5 (de) 1984-05-30
DK153485C (da) 1988-11-21
FR2423490A1 (fr) 1979-11-16
NL7902444A (nl) 1979-10-05
DE2913295C2 (fr) 1988-09-22
IE48278B1 (en) 1984-11-28
IT7948569A0 (it) 1979-04-02
JPS6256874B2 (fr) 1987-11-27
SE7902915L (sv) 1979-10-04
IT1116537B (it) 1986-02-10
DK130079A (da) 1979-10-04
ZA791525B (en) 1980-11-26
GB2019836A (en) 1979-11-07
LU81107A1 (fr) 1979-11-07
JPS54141797A (en) 1979-11-05
US4192944A (en) 1980-03-11

Similar Documents

Publication Publication Date Title
EP0454831B1 (fr) Dérivés de diazine comme antagonistes des recepteurs à l'angiotensine II
JP2815617B2 (ja) 縮合ピリミジン誘導体およびその製造方法
JP3599350B2 (ja) 新規なｎ−置換キノリン誘導体、それらの製造法、それらの薬剤としての使用及びそれらを含有する製薬組成物
US5474996A (en) Pyrimidine derivatives
JPS61293984A (ja) 活性化合物、その製法及びそれを含む医薬組成物
JPH07188165A (ja) ５，６−双環性グリコプロテインＩＩｂ／ＩＩＩａ拮抗剤
CN105518005A (zh) 作为rock抑制剂的三环吡啶-甲酰胺衍生物
IE67808B1 (en) Pyridine and pyridine N-oxide derivatives of diarylmethyl- piperidines or piperazines compositions and use thereof
EP0430300A2 (fr) Dérivés de xanthine, leur préparation et application
JP2000511173A (ja) 一酸化窒素産生阻害剤としての新規なインドリルおよびベンゾフラニルカルボキサミド
CA1337072C (fr) [4,5-c] imidazopyridines a substituant en 5
JP2531304B2 (ja) 新規アミノピペラジン誘導体
CA1130283A (fr) Derives de la theophylline et procede de preparation
EP0168005B1 (fr) Dérivés de semicarbazide, procédés pour leur préparation et compositions pharmaceutiques les contenant
SE440652B (sv) 4-oxo-4h-pyrido(1,2-a)pyrimidin-3-n-(1h-tetrazol-5-yl) karboxamidderivat och farmaceutisk komposition
US4147694A (en) 8-(1H-Tetrazol-5-yl-carbamoyl)quinoline compounds
US20040067955A1 (en) Pyridazinone compound and pharmaceutical use thereof
EP0642514B1 (fr) Derives pontes de bis-aryle carbinol, compositions et procedes d'utilisation
KR860000104B1 (ko) 2-피리딘 카복스아미드 유도체의 제조방법
DE69029303T2 (de) 5-Triazolo(3,4-i)purinderivate
CA1188303A (fr) 5-(pyridinyl)-1h-benzimidazoles et 1-hydroxy-6- (pyridinyl)-1h-benzimidazoles; preparation et emploi comme cardiotoniques
US4758559A (en) Pyrrolo[1,2-a] [4,1]benzoxazepine derivatives useful as calmodulin and histamine inhibitors
JPH0692915A (ja) １，２−ジアミノシクロブテン−３，４−ジオン誘導体及びその用途
US4024255A (en) Tetrazole containing naphthyridine-3-carboxamides
US5310916A (en) Trifunctional agents useful as irreversible inhibitors of A1-adenosine receptors

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7902915-3

Effective date: 19941110

Format of ref document f/p: F